346 related articles for article (PubMed ID: 24136009)
1. Pilot studies for personalized cancer medicine: focusing on the patient for treatment selection.
De Mattos-Arruda L; Rodon J
Oncologist; 2013; 18(11):1180-8. PubMed ID: 24136009
[TBL] [Abstract][Full Text] [Related]
2. Personalized Medicine: Genomics Trials in Oncology.
Hayes DF; Schott AF
Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
[TBL] [Abstract][Full Text] [Related]
3. Perspective on Precision Medicine in Oncology.
Johnson TM
Pharmacotherapy; 2017 Sep; 37(9):988-989. PubMed ID: 28632968
[TBL] [Abstract][Full Text] [Related]
4. Integrating precision cancer medicine into healthcare-policy, practice, and research challenges.
Bertier G; Carrot-Zhang J; Ragoussis V; Joly Y
Genome Med; 2016 Oct; 8(1):108. PubMed ID: 27776531
[TBL] [Abstract][Full Text] [Related]
5. Building a personalized medicine infrastructure at a major cancer center.
Meric-Bernstam F; Farhangfar C; Mendelsohn J; Mills GB
J Clin Oncol; 2013 May; 31(15):1849-57. PubMed ID: 23589548
[TBL] [Abstract][Full Text] [Related]
6. Enabling Precision Oncology Through Precision Diagnostics.
Brown NA; Elenitoba-Johnson KSJ
Annu Rev Pathol; 2020 Jan; 15():97-121. PubMed ID: 31977297
[TBL] [Abstract][Full Text] [Related]
7. Integrating genomics into clinical oncology: ethical and social challenges from proponents of personalized medicine.
McGowan ML; Settersten RA; Juengst ET; Fishman JR
Urol Oncol; 2014 Feb; 32(2):187-92. PubMed ID: 24445286
[TBL] [Abstract][Full Text] [Related]
8. AACR precision medicine series: Highlights of the integrating clinical genomics and cancer therapy meeting.
Maggi E; Montagna C
Mutat Res; 2015 Dec; 782():44-51. PubMed ID: 26554403
[TBL] [Abstract][Full Text] [Related]
9. Disparity between Inter-Patient Molecular Heterogeneity and Repertoires of Target Drugs Used for Different Types of Cancer in Clinical Oncology.
Zolotovskaia MA; Sorokin MI; Petrov IV; Poddubskaya EV; Moiseev AA; Sekacheva MI; Borisov NM; Tkachev VS; Garazha AV; Kaprin AD; Shegay PV; Giese A; Kim E; Roumiantsev SA; Buzdin AA
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32111026
[TBL] [Abstract][Full Text] [Related]
10. Precision oncology based on omics data: The NCT Heidelberg experience.
Horak P; Klink B; Heining C; Gröschel S; Hutter B; Fröhlich M; Uhrig S; Hübschmann D; Schlesner M; Eils R; Richter D; Pfütze K; Geörg C; Meißburger B; Wolf S; Schulz A; Penzel R; Herpel E; Kirchner M; Lier A; Endris V; Singer S; Schirmacher P; Weichert W; Stenzinger A; Schlenk RF; Schröck E; Brors B; von Kalle C; Glimm H; Fröhling S
Int J Cancer; 2017 Sep; 141(5):877-886. PubMed ID: 28597939
[TBL] [Abstract][Full Text] [Related]
11. Changing Landscape of Clinical-Genomic Oncology Practice.
Trivedi H; Kling HM; Treece T; Audeh W; Srkalovic G
Acta Med Acad; 2019 Apr; 48(1):6-17. PubMed ID: 31264429
[TBL] [Abstract][Full Text] [Related]
12. Challenges in initiating and conducting personalized cancer therapy trials: perspectives from WINTHER, a Worldwide Innovative Network (WIN) Consortium trial.
Rodon J; Soria JC; Berger R; Batist G; Tsimberidou A; Bresson C; Lee JJ; Rubin E; Onn A; Schilsky RL; Miller WH; Eggermont AM; Mendelsohn J; Lazar V; Kurzrock R
Ann Oncol; 2015 Aug; 26(8):1791-8. PubMed ID: 25908602
[TBL] [Abstract][Full Text] [Related]
13. Clinical Trials in the Evolving Landscape of Precision Medicine.
Cancer Cell; 2020 Jul; 38(1):3-8. PubMed ID: 32663468
[TBL] [Abstract][Full Text] [Related]
14. Revolutionizing Precision Oncology through Collaborative Proteogenomics and Data Sharing.
Rodriguez H; Pennington SR
Cell; 2018 Apr; 173(3):535-539. PubMed ID: 29677503
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of whole-genome sequencing in precision oncology.
Rosenquist R; Cuppen E; Buettner R; Caldas C; Dreau H; Elemento O; Frederix G; Grimmond S; Haferlach T; Jobanputra V; Meggendorfer M; Mullighan CG; Wordsworth S; Schuh A
Semin Cancer Biol; 2022 Sep; 84():32-39. PubMed ID: 34175442
[TBL] [Abstract][Full Text] [Related]
16. Key Lessons Learned from Moffitt's Molecular Tumor Board: The Clinical Genomics Action Committee Experience.
Knepper TC; Bell GC; Hicks JK; Padron E; Teer JK; Vo TT; Gillis NK; Mason NT; McLeod HL; Walko CM
Oncologist; 2017 Feb; 22(2):144-151. PubMed ID: 28179575
[TBL] [Abstract][Full Text] [Related]
17. The Master Protocol Concept.
Redman MW; Allegra CJ
Semin Oncol; 2015 Oct; 42(5):724-30. PubMed ID: 26433553
[TBL] [Abstract][Full Text] [Related]
18. Progress in precision therapy in pediatric oncology.
O'Donohue T; Farouk Sait S; Glade Bender J
Curr Opin Pediatr; 2023 Feb; 35(1):41-47. PubMed ID: 36377257
[TBL] [Abstract][Full Text] [Related]
19. National Cancer Institute's Precision Medicine Initiatives for the new National Clinical Trials Network.
Abrams J; Conley B; Mooney M; Zwiebel J; Chen A; Welch JJ; Takebe N; Malik S; McShane L; Korn E; Williams M; Staudt L; Doroshow J
Am Soc Clin Oncol Educ Book; 2014; ():71-6. PubMed ID: 24857062
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenomic biomarkers for personalized cancer treatment.
Rodríguez-Antona C; Taron M
J Intern Med; 2015 Feb; 277(2):201-217. PubMed ID: 25338550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
